A PTAFR antagonist reduced inflammation-induced colon carcinogenesis in rats, and β-catenin was localized in the cell membrane in healthy tissue, while it was overexpressed in the nucleus in precursor lesions and colon cancer [55]. Here, PTAFR is linked to malignant colon neoplasm.